4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-24-052603
Director bought 4,716 shares at an average $1.74 ($8,209)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Krogulski Kenneth Director | 2024-12-02 | Purchase 10b5-1 | +415 | $1.33 | $552 | 272,042 | D |
| Krogulski Kenneth Director | 2024-12-03 | Purchase 10b5-1 | +415 | $1.26 | $523 | 272,457 | D |
| Krogulski Kenneth Director | 2024-12-04 | Purchase 10b5-1 | +415 | $1.22 | $506 | 272,872 | D |
| Krogulski Kenneth Director | 2024-12-05 | Purchase 10b5-1 | +350 | $1.20 | $420 | 273,222 | D |
| Krogulski Kenneth Director | 2024-12-06 | Purchase 10b5-1 | +415 | $1.20 | $498 | 273,637 | D |
| Krogulski Kenneth Director | 2024-12-09 | Purchase 10b5-1 | +415 | $1.25 | $519 | 274,052 | D |
| Krogulski Kenneth Director | 2024-12-10 | Purchase 10b5-1 | +197 | $2.48 | $489 | 274,249 | D |
| Krogulski Kenneth Director | 2024-12-11 | Purchase 10b5-1 | +197 | $2.29 | $451 | 274,446 | D |
| Krogulski Kenneth Director | 2024-12-12 | Purchase 10b5-1 | +197 | $2.19 | $431 | 274,643 | D |
| Krogulski Kenneth Director | 2024-12-13 | Purchase 10b5-1 | +197 | $2.33 | $459 | 274,840 | D |
| Krogulski Kenneth Director | 2024-12-16 | Purchase 10b5-1 | +312 | $2.21 | $690 | 275,152 | D |
| Krogulski Kenneth Director | 2024-12-17 | Purchase 10b5-1 | +312 | $2.12 | $661 | 275,464 | D |
| Krogulski Kenneth Director | 2024-12-18 | Purchase 10b5-1 | +312 | $2.19 | $683 | 275,776 | D |
| Krogulski Kenneth Director | 2024-12-19 | Purchase 10b5-1 | +266 | $2.33 | $620 | 276,042 | D |
| Krogulski Kenneth Director | 2024-12-20 | Purchase 10b5-1 | +301 | $2.35 | $707 | 276,343 | D |
| Open-market purchases · 4,716 sh · avg $1.74 · $8,209 | |||||||
Loading xslF345X05/wk-form4_1735605706.xml…